CounterAct
- Product NDC
- 54473-305
- 11-digit product format
- 544730305
- Labeler code
- 54473
- Product ID
- 54473-305_30ce656f-cab7-9520-e063-6294a90a43ff
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Melaleuca, Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-05-02
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CounterAct
- Brand name suffix
- Pain
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54473-305-50 | 2025-03-21 | C162847 | 48780-1 | 2cef2736-aae7-d83d-e063-dadaa90ab31f | CounterAct Pain Content of Labeling |
| 54473-305-50 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-aae7-d83d-e063-dadaa90ab31f | CounterAct Pain Content of Labeling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54473-305-50 | CounterActPain | 50 in 1 BOTTLE | TABLET, FILM COATED | 50 | 3 | |
| 54473-305-50 | CounterActPain | 1 in 1 BOX | TABLET, FILM COATED | 1 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | M013 |
| MOTRIN IB | IBUPROFEN | R J General Corporation | afa87bb5-7fcb-4ccd-acac-f7931242181f | 2025-11-17 | Warnings | M013 |
| TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | 99e45e83-37a3-44df-9a2a-98ba7457a5bb | 2025-11-17 | Warnings | M013 |
| TYLENOL PM EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | a40ea0e3-d666-4605-b5e0-beeaf8f586f2 | 2025-11-17 | Warnings | M013 |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG | R J General Corporation | 68d3be55-9340-4cc9-a05a-12b9338ddc56 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | dd9aaf80-6c2b-41a3-87b9-61642aaed4f0 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c18a2da-1718-4c00-aea8-9fb4a3418312 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | cd3060a5-3b90-42e4-89cd-3b620859045f | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c7221ae-52d1-4d18-b586-c47ff656150d | 2025-11-17 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | R J General Corporation | 907c89e7-2482-465f-9f85-2381ecab1b86 | 2025-11-17 | Warnings | M013 |
| Bayer Genuine Aspirin | ASPIRIN | R J General Corporation | 23daa359-d40f-4f64-81be-6d154f41df9f | 2025-11-17 | Warnings | M013 |
| EXTRA STRENGTH PAIN RELIEVER | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Geri-Care Pharmaceutical Corp | b670a898-2360-76e2-e053-2a95a90a3380 | 2025-11-17 | Warnings | M013 |
| Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | L.N.K. International, Inc. | ec902e52-0f48-4a61-b67d-17e1c1461619 | 2025-11-15 | Warnings | M013 |
| Pain Reliever Extra Strength | ACETAMINOPHEN | L.N.K. International, Inc. | 72babe91-2586-4f05-ae90-6debfd23aa5d | 2025-11-15 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | Strategic Sourcing Services LLC | 3c7883da-6f51-4716-b012-0e33d239a60e | 2025-11-15 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | Sam's West Inc | 3b84746f-05ab-4f88-b9ae-efb8c5dfc233 | 2025-11-15 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | Walgreen Company | a482e715-bec0-44a4-bb0e-ea5f5fda558e | 2025-11-15 | Warnings | M013 |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | ARMY AND AIR FORCE EXCHANGE SERVICE | f1157dbc-d86c-4554-954c-60a74674ff6b | 2025-11-15 | Warnings | M013 |
| Acetaminophen, Aspirin, Caffeine | ACETAMINOPHEN, ASPIRIN, CAFFEINE | NuCare Pharmaceuticals,Inc. | 437e4fd9-c7d9-77d6-e063-6294a90a22b7 | 2025-11-13 | Warnings | M013 |
| Good Sense Pain Relief | ACETAMINOPHEN | L. Perrigo Company | 7f78028a-484b-48b3-a37a-1e0b055bbefc | 2025-11-13 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | CounterAct Pain 500 MG Oral Tablet | PSN | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | acetaminophen 500 MG Oral Tablet [CounterAct Pain] | SBD | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 198440 | APAP 500 MG Oral Tablet | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | APAP 500 MG Oral Tablet [CounterAct Pain] | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | CounterAct Pain 500 MG Oral Tablet | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 54473-305-50 | 54473030550 | 1 BOTTLE in 1 BOX (54473-305-50) / 50 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2018-01-01 | 0000-00-00 | No | No | Current |